Abstract: Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical keratinized skin formulation vehicle, and methods of using these formulations to inhibit skin irritation in keratinized skin, are disclosed.
Abstract: Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical formulation vehicle, and methods of using these formulations to inhibit skin irritation, are disclosed.
Abstract: Topical formulations containing aqueous-soluble divalent strontium cation in a suitable topical formulation vehicle, and methods of using these formulations to inhibit skin irritation, are disclosed.
Abstract: Composition and methods are provided for inhibiting skin irritation attributable to chemical irritants or environmental conditions, by the application of an anti-irritant amount of aqueous-soluble strontium cation.
Abstract: Compositions and methods are provided for inhibiting skin irritation attributable to chemical irritants, including skin exfoliant irritants, and environmental conditions by the application of an anti-irritant amount of aqueous-soluble divalent calcium cation.
Abstract: Topical formulations comprising an anti-irritant amount of aqueous-soluble strontium (Sr.sup.2+) cation, and method for using the same to inhibit skin irritation are disclosed.
Type:
Grant
Filed:
June 20, 1996
Date of Patent:
September 8, 1998
Assignee:
Cosmederm Technologies
Inventors:
Gary S. Hahn, David O. Thueson, Timothy W. Quick
Abstract: Topical formulations comprising an anti-irritant amount of aqueous-soluble lithium (Li.sup.+) or potassium (K.sup.+) cation, and methods for using the same to inhibit skin irritation, are disclosed.
Abstract: Topical formulations comprising an anti-irritant amount of aqueous-soluble strontium (Sr.sup.2+) cation, and methods for using the same to inhibit skin irritation, are disclosed.